| [1] | Greenlee, W.J., 1990, Renin inhibitors., Medicinal Research Reviews, 10(2), 173–236. |
| [2] | Jensen, C., Herold, P., and Brunner, R., 2008, Aliskiren: the first renin inhibitor for clinical treatment., Nature Review Drug Discovery, 7(5), 399–410. |
| [3] | Pachauri, S., Paliwal, S., Srinivas, K.S., Singh, Y., and Jain, V., 2010, Development and validation of HPLC method for analysis of some antihypertensive agents in their pharmaceutical dosage forms., Journal of Pharmaceutical Sciences and Research, 2(8), 459–464. |
| [4] | Swamy, G.K., Rao, J.V.L.N.S., Kumar, J.M.R., Kumar, U.A., Bikshapathi, D.V.R.N., and Kumar, D.V., 2011, Analytical method development and validation of aliskiren in bulk and tablet dosage form by RP-HPLC method., Journal of Pharmacy Research, 4(3), 865–867. |
| [5] | Swamy, G.K., Kumar, J.M.R., Rao, J.V.L.N.S., and Surekha, M.L., 2012, Validated RP-HPLC method for simultaneous estimation of aliskiren and valsartan in tablet dosage form., Journal of Drug Delivery and Therapeutics, 2(5), 162–166. |
| [6] | Swamy, G.K., Sravanthi, P., Surekha, M.L., Kumar, J.M.R., and Rao, J.V.L.N.S., 2012, Validated RP-HPLC method for the simultaneous determination of aliskiren, hydrochlorothiazide and amlodipine besylate in bulk and pharmaceutical formulations., International Journal of ChemTech Research, 4(4), 1666–1673. |
| [7] | Babu, K.S., Rao, J.V.L.N.S., and Bhargava, K.V., 2011, A simple and sensitive method for the determination of aliskiren hemifumarate using HPLC-UV detection., RASAYAN Journal of Chemistry, 4(2), 285–288. |
| [8] | Wrasse-Sangoi, M., Sangoi, M.S., Oliveira, P.R., Secretti, L.T., and Rolim, C.M.B., 2011, Determination of aliskiren in tablet dosage forms by a validated stability-indicating RP-LC method., Journal of Chromatographic Science, 49(2), 170–175. |
| [9] | Wrasse-Sangoi, M., Secretti, L.T., Diefenbach, I.F., Rolim, C.M.B., and Sangoi, M.D., 2010, Development and validation of an UV spectrophotometric method for the determination of aliskiren in tablets., Quimica Nova, 33(6), 1330–1334. |
| [10] | Sangoi, M.S., Wrasse-Sangoi, M., Oliveira, P.R., Rolim, C.M.B., and Steppe, M., 2011, Simultaneous determination of aliskiren and hydrochlorothiazide from their pharmaceutical preparations using a validated stability-indicating MEKC method., Journal of Separation Science, 34, 1859–1866. |
| [11] | Aydogmus, Z., Sari, F., and Ulu, S.T., 2012, Spectrofluorimetric determination of aliskiren in tablets and spiked human plasma through derivatization with dansyl chloride., Journal of Fluorescence, 22(2), 549–556. |
| [12] | International Conference on Harmonization, ICH, 2005, Validation of analytical procedures – Text and methodology, Geneva, Switzerland, Q2 (R1). |
| [13] | Job, P., 1964, Advanced physicochemical experiments, 2nd ed., Oliner and Boyd, Edinburgh, UK. |
| [14] | Rose, J., 1964, Advanced physicochemical experiments, Pitman, London, UK. |
| [15] | Aswani Kumar, C., Kumar, T., Gurupadayya, B., Sloka, S., and Reddy, M., 2010, Novel spectrophotometric determination of valacyclovir and cefotaxime using 1,2 – naphthaquinone -4-sulfonis acid sodium in bulk and pharmaceutical dosage form., Archives of Applied Science Research, 2(4), 278–287. |
| [16] | Aswani Kumar, C., Gurupadayya, B., Sloka, S., Chandan, R., and Thejaswini, J., 2011, Colorimetric determination of cefadroxil and ceftriaxone in pharmaceutical dosage forms., Tropical Journal of Pharmaceutical Research, 10(1), 81–88. |
| [17] | Aswani Kumar, C., Gurupadayya, B., Sloka, S., and Kandula, P., 2011, Spectrophotometric determination some cephalosporins containing amino group using 1,2 – naphthqquinone -4-sulfonic acid sodium in pharmaceutical dosage form., International Journal of Pharmacy and Technology, 3(1), 1750–1767. |
| [18] | The United States Pharmacopoeia, USP 30 NF 25, 2007, United States Pharmacopoeial Convention, 30th ed., Rockville, MD, USA. |
| [19] | Saurina, J., and Hernandez-Cassou, S., 1993,Continuous-flow spectrophotometric determination of amino acids with 1,2-naphthoquinone-4-sulfonate reagent., Analytica Chimica Acta, 283(1),414–420. |
| [20] | Fidler, A.T., Baker, E.L., and Letz, R.E., 1987,Neurobehavioural effects of occupational exposure to organic solvents among construction painters., British Journal of Industrial Medicine, 44(5), 292–308. |
| [21] | Wennborg, H., Lennart, B., Harri, V., and Gosta, A., 2000, Pregnancy outcome of personnel in Swedish biomedical research laboratories., Journal of Occupational and Environmental Medicine, 42(4), 438–446. |
| [22] | Wennborg, H., Bonde, J.P., Stenbeck, M., and Olsen, J., 2002, Adverse reproduction outcomes among employee in biomedical research laboratories., Scandinavian Journal of Work, Environment and Health, 28(1), 5–11. |
| [23] | Lindbohm, M.L., Taskinen, H.T., Sallman, M., and Hemminki, K., 1990, Spontaneous abortions among women exposed to organic solvents., American Journal of Industrial Medicine, 17(4), 449–463. |
| [24] | Kristensen, P., Hilt, B., Svendsen, K., and Grimsrud, T.K., 2008, Incidence of lymphohaematopoietic cancer at university laboratory: a cluster investigation., European Journal of Epidemiology, 23(1), 11–15. |
| [25] | Ali, A., and Elbashir, A., 2012, Spectrophotometric determination of lisinopril dihydrate in pharmaceutical formulations using sodium 1,2-naphthoquinone-4-sulfonic., ISESCO Journal of Science and Technology, 8(13), 30–36. |
| [26] | Hadad, G.M., Abdel-Salam, R.A., and Emara, S., 2012, Determination of glucosamine and carisoprodol inpharmaceutical formulations by LC with pre-column derivatization and UV detection., Journal of Chromatographic Science, 50(4), 307–315. |
| [27] | Babu, A.B., Ramu, G., Rao, S.V., Neeharika, T., and Rambabu, C., 2011, Spectrophotometric determination of an antiretroviral drug stavudine in bulk and pharmaceutical formulations., RASAYAN Journal of Chemistry, 4(2), 336–342. |